Ziv-aflibercept biosimiliar (Boan Biopharma)

N/A

Report date: 2025/08/01 14:25:38

Base Information

Drug NameZiv-aflibercept biosimiliar (Boan Biopharma)
Drug Alias NameZaltrap生物类似药（山东博安/绿叶制药）Ziv-阿柏西普生物类似药（山东博安/绿叶制药）重组人血管内皮生长因子受体-抗体融合蛋白注射液（山东博安/绿叶制药）Ziv-阿柏西普生物类似药（博安生物）LY-01012 +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Biosimilar
Mechanisms of ActionPlacental Growth Factor inhibitorsVascular endothelial growth factor A inhibitorsVascular endothelial growth factor B inhibitors
TargetsPlacental Growth FactorVascular endothelial growth factor AVascular endothelial growth factor B
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesShandong Boan Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLuye Pharma Group LtdShandong Boan Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A